Semaglutide May Increase Risk for Nonarteritic Anterior Ischemic Optic Neuropathy

MONDAY, Feb. 23, 2026 -- People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic neuropathy (NAION) versus those starting sodium-glucose cotransporter-2 inhibitors (SGLT2is), according...